B2B only. For licensed importers and distributors. Tender authorities and healthcare institutions are also served. Not for retail or patient supply.  ·  Compliance statement
万药达 wanyoda
wanyoda.
Export Mandate
EN 中文
Apply as distributor
Products Opportunities Partner with us Services Compliance About Apply as distributor →
EN 中文
Home/Compliance & credentials
Credentials

The document that
a trader cannot produce.

An export mandate is a signed authorisation from a manufacturer naming one company to represent its products abroad. It defines the product scope, the territory and the term. Traders source stock; they do not hold mandates.

Redacted copies are released to qualified partners and tender authorities under a mutual NDA. Full versions are shown on request during due diligence.

Export mandates

Three manufacturers, three letters.

Each letter names the product scope and the territories covered. Where the manufacturer has cleared publication, the approval number is printed on the product page. Where it has not, the page says so and the number is provided once an NDA is signed — the certificate always travels with the dossier.

Export mandate · 01

China Resources Boya Bio-pharmaceutical Group

Written authorisation, signed and sealed by the manufacturer.
Scope
Albumin · IVIG · rabies Ig · factor VIII · PCC · fibrinogen
Territory
Markets outside mainland China
Status
On file
A redacted original is released with the due-diligence pack. Request the file
Export mandate · 02

Beijing Bohui Innovation Biotechnology Group

Written authorisation, signed and sealed by the manufacturer.
Scope
Plasma-derived products · rabies vaccine (hamster kidney cell)
Territory
Markets outside mainland China
Status
On file
A redacted original is released with the due-diligence pack. Request the file
Export mandate · 03

Guangzhou Baiyunshan Bioproducts

Written authorisation, signed and sealed by the manufacturer.
Scope
Freeze-dried rabies vaccine (Vero cell)
Territory
Markets outside mainland China
Status
On file
A redacted original is released with the due-diligence pack. Request the file

These cards summarise scope; they are not reproductions. No document image is displayed on this site at any size. The signed originals are shown on request, with personal identifiers, pricing terms and internal references removed before release.

Regulatory record

Audits passed, in the order they happened.

Publicly documented regulatory events behind the portfolio. These are the facts a tender authority can verify independently — which is precisely why they are listed with dates.

2019.07
Sri Lankan official GMP on-site audit passedManufacturing site inspection
Boya
2019
First export of IVIG to BrazilCommercial market entry
Boya
2020.01
Turkish official GMP on-site audit passedManufacturing site inspection
Boya
2020–21
Approx. USD 25 million of IVIG supplied to BrazilReference shipment record
Boya
2021
Türkiye GMP certificate issuedCertificate held by the manufacturer
Boya
2021
Philippines GMP waiver issuedCertificate held by the manufacturer
Boya
—
23 plasma collection centres across four production basesCapacity and traceability
Bohui
—
Overseas registration not yet initiatedJoint filing with the appointed partner
Baiyunshan
Due-diligence pack

What we send when you ask properly.

Released under mutual NDA to licence-holding partners, tender authorities and manufacturer prospects. Issued within five working days of qualification.

Request the pack
▤Redacted export mandate letters (3)
▤GMP certificates and audit confirmations
▤Product approval numbers and registration certificates
▤Sample Certificate of Analysis and batch release
▤Corporate licence and foreign trade registration
▤Bank reference and credit standing
▤Export packing validation and handover protocol
▤Reference shipment summary by market
Clarity

What we are not.

Negative statements are easier to verify than positive ones, so we lead with them.

Not a trading company

We do not buy stock and resell it. Title to the goods passes from manufacturer to buyer.

Not a domestic distributor

Our mandates cover markets outside mainland China only. We do not compete with the manufacturer at home.

Not a pharmacy or retailer

No supply to individuals. Every enquiry is qualified against a licence before it is answered commercially.

Not a marketing agent

We carry registration, documentation and export accountability, not just introductions.

Compliance statement

Rules this site operates under.

Audience restriction

This website addresses licensed importers, distributors, procurement authorities and healthcare institutions. It is not directed at the general public and contains no promotion of medicines to consumers.

No efficacy or safety claims

Product descriptions are limited to composition, presentation, storage and licensing. Approved indications, posology and warnings are set out only in the marketing authorisation and the approved product information of the destination market.

No pricing published

No price, discount or commercial term appears on this site. Quotations are issued per destination, per volume and per registration status, in writing.

Registration status is market-specific

A product licensed in China is not thereby licensed elsewhere. Where we state a registration position we name the market and the basis; where no filing exists we say so rather than implying availability.

Anti-bribery

We do not offer or accept inducements to procurement staff, prescribers or officials. Dealings with public tender authorities are documented and auditable. Any request for an improper payment terminates the discussion.

Data

Enquiry data is used to qualify and respond to the enquiry and is not sold. Regulatory documents are released under NDA and stored accordingly. Requests for deletion are honoured within 30 days.

Due diligence

Verify us before you negotiate.

Ask for the mandate letters and the regulatory record. A supplier who resists that request has answered your question already.

Request the due-diligence pack → About wanyoda